SeaBeLife

SeaBeLife

Developing a range of medications to block regulated necrosis (or regulated cell death), from two families of patented molecules.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor investor investor investor investor

€0.0

round
*

$1.5m

Grant
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2020
Revenues0000
EBITDA0000
Profit0000
EV0000
EV / revenue00.0x
EV / EBITDA00.0x
R&D budget0000

Source: Company filings or news article

Notes (0)
More about SeaBeLife
Made with AI
Edit

SeaBeLife is at the forefront of developing groundbreaking molecules aimed at inhibiting necroptosis, a form of programmed cell death implicated in severe medical conditions. The company focuses on creating medication candidates to address urgent medical needs in emergency medicine, particularly targeting acute liver failure (ALF) and acute kidney injury (AKI). By prioritizing the development of these innovative treatments, SeaBeLife aims to improve patient outcomes and save lives by preventing complications associated with these critical disorders. The business model revolves around the research and development of patented molecules, with the potential to generate revenue through successful clinical trials and partnerships with pharmaceutical companies. SeaBeLife serves healthcare providers and patients in the emergency medicine sector, addressing a significant gap in the market for effective treatments against necroptosis-related conditions. Keywords: necroptosis, emergency medicine, acute liver failure, acute kidney injury, molecules, programmed cell death, critical disorders, medication development, healthcare, patient outcomes.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads